Non-glycosylated IGF2 prohormones are more mitogenic than native IGF2
Open accessPreprint — published as 10.1038/s42003-023-05239-6
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Insulin-like Growth Factor-2 (IGF2) is important for the regulation of human embryonic growth and development, and for adults’ physiology. Incorrect processing of the IGF2 precursor, pro-IGF2(156), leads to the formation of two IGF2 proforms, big-IGF2(87) and big-IGF2(104). Unprocessed and mainly non-glycosylated IGF2 proforms are found at abnormally high levels in certain diseases, but their mode of action is still unclear. Here, we found that pro-IGF2(156) has the lowest ability to form its inactivating complexes with IGF-Binding Proteins and has higher proliferative properties in cells than IGF2 and other IGF prohormones. We also showed that big-IGF2(104) has a seven-fold higher binding affinity for the IGF2 receptor than IGF2, and that pro-IGF2(87) binds and activates specific receptors and stimulates cell growth similarly to the mature IGF2. The properties of these pro-IGF2 forms, especially of pro-IGF2(156) and big-IGF2(104), indicate them as hormones that may be associated with human diseases related to the accumulation of IGF-2 proforms in the circulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Research works printed but not linked: 69
- 10.1016/j.tins.2011.12.007 · DOI · Paper page
- 10.1186/S40792-018-0508-2 · DOI
- 10.1007/s00216-021-03423-3 · DOI
- 10.1210/jc.80.9.2700 · DOI · Paper page
- 10.1210/jc.2013-3525 · DOI
- 10.1677/joe.0.1650253 · DOI · Paper page
- 10.1056/NEJM198812013192202 · DOI · Paper page
- 10.1073/pnas.86.17.6778 · DOI · Paper page
- 1994, Unglycosylated Big Igf-Ii in Nonislet Cell Tumor Hypoglycemia (Nicth) and Its Serum Binding, Insulin-Like Growth Factors and Their Regulatory Proteins, 1056, 77
- 10.1073/pnas.90.12.5823 · DOI · Paper page
- 10.1007/BF02935648 · DOI
- 10.1677/ERC-07-0161 · DOI · Paper page
- 10.1074/jbc.273.29.18443 · DOI · Paper page
- 10.1210/er.2012-1033 · DOI · Paper page
- 1999, Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells, MolCell Biology, 19, 3278
- 10.1007/s001250050951 · DOI
- 10.1016/j.ghir.2006.05.003 · DOI · Paper page
- 10.1074/jbc.M112.432013 · DOI
- 10.1074/jbc.272.44.27936 · DOI
- 10.1523/JNEUROSCI.2730-05.2006 · DOI · Paper page
- 10.1074/jbc.M116.741041 · DOI
- 10.2169/internalmedicine.9287-17 · DOI
- 10.1210/jc.83.8.2875 · DOI · Paper page
- 10.3390/cells8101207 · DOI
- 10.2169/internalmedicine.54.4945 · DOI
- 10.1530/eje.0.1390317 · DOI
- 10.1677/JOE-07-0619 · DOI
- 10.1530/EJE-13-1012 · DOI · Paper page
- 10.1016/j.ando.2018.01.005 · DOI
- 10.1210/edrv-16-1-3 · DOI · Paper page
- 10.1002/bip.360221211 · DOI · Paper page
- 10.1016/j.ecl.2012.04.013 · DOI · Paper page
- 10.1210/jc.2018-00593 · DOI
- 10.1210/jc.87.8.3867 · DOI · Paper page
- 10.1172/JCI1111 · DOI · Paper page
- 10.1038/s41467-022-32214-2 · DOI
- 2006, Insulin-like growth factors Seminars in Medicine of the Beth Israel Deaconess Medical Center, 336, 633
- 10.1016/j.molmet.2021.101245 · DOI · Paper page
- 10.1074/jbc.RA119.010072 · DOI
- 10.1210/en.2010-0784 · DOI
- 10.1210/jc.86.8.3665 · doi:10.1210/jc.86.8.3665 · Paper page
- 10.1093/nar/gkac345 · DOI · Paper page
- 10.1093/nar/gky497 · DOI · Paper page
- 10.1038/s41592-022-01488-1 · doi:10.1038/s41592-022-01488-1 · Paper page
- 10.1093/bioinformatics/bty1057 · DOI · Paper page
- 10.1074/jbc.270.38.22639 · DOI · Paper page
- 10.1074/jbc.M111.252478 · DOI · Paper page
- 2021, A case of nonislet cell tumor hypoglycemia associated with malignant mesothelioma requiring a multifaceted approach for optimal glycemic control, Clinical Case Reports, 9, 10
- 10.1371/journal.pone.0238393 · DOI
- 10.1016/j.ghir.2009.11.001 · DOI
- 10.1158/1078-0432.CCR-18-2697 · DOI
- 10.1128/MCB.14.6.3604 · DOI · Paper page
- 10.1038/nbt0602-592 · DOI · Paper page
- 10.1016/j.neurobiolaging.2016.04.006 · DOI · Paper page
- 10.1002/wsbm.1196 · DOI
- 10.1507/endocrj.K08E-062 · DOI
- 10.1016/j.celrep.2019.04.066 · DOI · Paper page
- 10.1074/jbc.272.8.4804 · DOI
- 10.1002/biof.1623 · DOI
- 10.1016/j.ghir.2014.08.002 · DOI
- 10.1016/0002-9343(92)90165-8 · DOI
- 10.1126/sciadv.aaz1466 · DOI
- 10.1126/science.1228633 · DOI
- 10.1016/j.str.2007.07.007 · DOI
- 10.1016/j.str.2020.05.002 · DOI
- 10.1210/en.137.7.2766 · doi:10.1210/en.137.7.2766
- 10.7554/eLife.54781 · DOI · Paper page
- 10.1107/S1399004714017775 · DOI
- 10.1172/JCI116152 · DOI · Paper page
Metadata
- Authors
- Potalitsyn, P., Mrázková, L., Selicharová, I., Tencerová, M., Ferenčáková, M., Chrudinová, M., Brzozowski, A. M., Marek, A., Kaminský, J., Jiráček, J., & Žáková, L.
- Affiliations
- Czech Academy of Sciences (CZ)
- University of York (GB)
- Corresponding author
- Žáková, Lenka
- ORCID
- Venue
- Communications Biology
- Publisher
- openRxiv
- Published
- 2023-01-18
- Volume
- 6
- Issue
- 1
- Pages
- 863-863
- ISSN
- 2399-3642 (ISSN-L)
- PMC
- PMC10439913
- OpenAlex
- W4386001747
- Cited by
- 12
- References
- 1
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 1 · 2023: 1
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Communications Biology (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Research Councils UK (BB/W003783/1)
- European Commission (CZ.02.1.01, LX22NPO5104)
- Grantová Agentura České Republiky (CZ.02.1.01/0.0, CZ.02.1.01/0.0/0.0/16019/0000729, GA19-14069S, CZ.02.1.01, LX22NPO5104)
- Akademie Věd České Republiky (LX22NPO5104, 6138963, RVO:6138963)
- Medical Research Council (MR/R009066/1)
- Biotechnology and Biological Sciences Research Council (BB/W003783/1)
- European Regional Development Fund (02.1.01/0.0/0.0, .02.1.01/0.0/0.0/16_019/0000729, CZ.02.1.01/ 0.0/0.0/16_019/0000729, CZ.02, 16_019/0000729, CZ.02.1.01, CZ.02.1.01/0.0/0.0, /16_019)
- NextGenerationEU
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- insulin-like growth factor II, IGF binding proteins, cell proliferation, mitogenic activity
- MeSH terms
- Adult, Cell Cycle, Humans, Insulin-Like Growth Factor II, Mitogens, Intercellular Signaling Peptides and Proteins, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.